Thymosin Alpha-1
Thymosin Alpha-1 (Tα1) is a 28-amino-acid thymic peptide, globally recognized as one of the most powerful immunomodulators in existence, approved as an orphan drug (Zadaxin) in 35+ countries. Rather than simply suppressing or boosting immunity blindly, Tα1 is an intelligent "immune orchestrator." It is clinically deployed against devastating pathologies including Hepatitis B/C, Lyme disease, aggressive fungal infections, and profound immunosenescence. It forcefully reboots an exhausted immune system, shifting it from a chaotic inflammatory state to a lethal, highly targeted cellular defense posture.
Quick Stats
Scientific Data
Patient Suitability
✓ Best For
- Chronic Hepatitis B or C SupportHelps clear viral loads and normalize liver enzymes
- Cancer Treatment SupportMay help maintain immune function alongside chemotherapy
- Age-Related Immune DeclineKeeps immune defenses more youthful and responsive
- Severe Infection RecoveryShown promise for reducing mortality by restoring immune balance (e.g. sepsis)
✗ Avoid If
- Organ transplant patients taking immunosuppressants
- Active autoimmune disease flare
- Pregnancy or breastfeeding
- Severe allergic reaction history
- Under 18 without medical supervision
! Use With Caution If
- Autoimmune condition (even in remission)
- Medications affecting immune function
- History of allergic reactions to peptides
- Cancer immunotherapy
- Kidney or liver disease
Mechanism of Action
Your immune system's master trainer—a naturally occurring thymus peptide that wakes up tired immune cells, helps your body fight infections, and keeps your defenses sharp as you age. Thymosin Alpha-1 (Tα1) plays a central role in adaptive immunity by orchestrating T-cell maturation, differentiation, and activation. Tα1 activates toll-like receptors (TLR2, TLR9), enhances dendritic cell presentation, stimulates natural killer (NK) cells, and promotes T-helper cell differentiation.
FDA-designated as an orphan drug (Zadaxin) and approved in 35+ countries for hepatitis B and C treatment. Clinical studies also demonstrate efficacy as an immune adjuvant in cancer therapy and vaccine enhancement. Uniquely, it has the ability to boost immunity while preventing harmful overreaction through IDO pathway activation.
Source: PMID: 17316418
Background & History
Thymosin Alpha-1 (Tα1, Thymalfasin) is a 28-amino-acid peptide isolated from the thymus gland in 1972 by Allan Goldstein at Albert Einstein College of Medicine — the same researcher who earlier discovered Thymosin Beta-4. It is one of the most studied immunomodulatory peptides with FDA orphan drug status for multiple conditions and commercial approval in 35+ countries (Zadaxin, SciClone Pharmaceuticals) for hepatitis B, hepatitis C, and various immunocompromised states. It is the flagship "thymic peptide" proven to restore immune competence.
Research Use Cases
- ✓Hepatitis B and C treatment (approved in 35+ countries as Zadaxin)
- ✓Immunocompromised states: chemotherapy, HIV, organ transplant recovery
- ✓Sepsis and critical illness immune support
- ✓Cancer immunotherapy adjunct — enhancing NK and T-cell activity
- ✓Long COVID immune restoration
Dosing Protocols
Starting Dose
Standard Protocol
Advanced Protocol
When to Increase:
- Tolerated the starting protocol well for 4+ weeks
- Healthcare provider recommends intensification
- Blood work shows continued immune markers that could benefit from support
When to Decrease:
- Persistent flu-like symptoms beyond the first week
- Injection site reactions don't improve with site rotation
- Develop signs of immune overstimulation
- Autoimmune symptoms emerge or worsen
Body-Weight Dosing Reference
Estimated doses extrapolated from the published research range of 1600–3200 mcg/day (referenced to 70 kg / 154 lb). These are approximations — consult a qualified healthcare provider for personalised guidance.
| Weight | Low Dose | Target Dose | High Dose |
|---|---|---|---|
| 120 lb(54 kg) | 1234 mcg | 1851 mcg | 2469 mcg |
| 140 lb(63 kg) | 1440 mcg | 2160 mcg | 2880 mcg |
| 160 lb(73 kg) | 1669 mcg | 2503 mcg | 3337 mcg |
| 180 lb(82 kg) | 1874 mcg | 2811 mcg | 3749 mcg |
| 200 lb(91 kg) | 2080 mcg | 3120 mcg | 4160 mcg |
| 220 lb(100 kg) | 2286 mcg | 3429 mcg | 4571 mcg |
| 250 lb(113 kg) | 2583 mcg | 3874 mcg | 5166 mcg |
💉 For exact syringe units based on your vial concentration, use the Thymosin Alpha-1 Reconstitution Calculator →
Administration & Storage
Preparation
- Bacteriostatic water (BAC water)
- Insulin syringes (29-31 gauge)
- Alcohol swabs
Storage Guidelines
Reconstitution Example
Safety & Considerations
Thymosin Alpha-1 has one of the most extensive safety records of any peptide, with decades of clinical use across multiple countries. Studies consistently report minimal side effects—mostly limited to mild injection site reactions. The 2-hour half-life means it does not accumulate in your system. It has been used safely in thousands of patients with hepatitis, cancer, and other serious conditions.
Regulatory & Legal Status
Approved in 37+ countries (including Italy, China) as Zadaxin®; not FDA-approved in the US
Competitive athletes subject to anti-doping controls should not use Thymosin Alpha-1.
Research Chemical
US Compounding: Not eligible / not available
⚠️ This information is for educational purposes only and may not reflect the most current regulatory updates. Always verify with official FDA, WADA, and jurisdiction-specific sources before use.
Interactions & Contraindications
Very favorable safety profile — used in critically ill patients without significant drug interactions. May potentiate effects of checkpoint inhibitors (immunotherapy drugs); monitor with oncology team. Do not combine with immunosuppressants (cyclosporine, tacrolimus) — opposing mechanisms.
Synergies & Common Stacks
BPC-157 handles tissue repair; Thymosin Alpha-1 restores immune competence. Together support comprehensive recovery from surgery, illness, or infection.
LL-37 provides direct antimicrobial activity while Tα1 amplifies systemic adaptive immune response. Combined immune support across innate and adaptive arms.
Thymosin Alpha-1 vs. TB-500
| Attribute | Thymosin Alpha-1 | TB-500 |
|---|---|---|
| Mechanism | Immune modulation + thymic activation | Actin polymerization + cell migration |
| Primary Use | Immune support, infection, cancer adjuvant | Physical tissue healing, injury recovery |
| Evidence Quality | Human trials (37+ country approval) | Primarily preclinical |
| WADA Status | Prohibited (S4) | Prohibited (S0) |
| Dose Frequency | 900 mcg – 1.6 mg 2× weekly | 2–5 mg 2× weekly |
Verdict: Thymosin Alpha-1 targets immunity; TB-500 targets tissue healing. These peptides address completely different goals with minimal overlap — they are not competing options but complementary tools.
What to Expect
Weeks 1-2
- Mild injection site reactions
- Possible flu-like symptoms
- Slightly more fatigue
- Nothing dramatic
- Side effects typically improve
- Continue twice-weekly schedule consistently
Weeks 3-4
- Injection tolerance improves significantly
- Feeling more resilient to minor bugs
- Energy levels stabilize
- Viral markers may start improving
- Continue consistent dosing
- Clinical benefits become measurable
Weeks 5-6+
- Established benefits maintained
- Fewer or shorter illnesses
- Improved lab markers
- Overall sense of immune competence
- Discuss continuation with provider
- Some protocols continue long-term; others take breaks
Dosing Quick Reference
Frequently Asked Questions
Is Thymosin Alpha-1 FDA-approved?▼
How does Thymosin Alpha-1 differ from Thymosin Beta-4 (TB-500)?▼
References
- Garaci E, Pica F, Matteucci C “"Historical review on thymosin α1 in oncology".” Expert Opin Biol Ther (2015). PMID: 26096345
- Romani L, Moretti S, Fallarino F “"Jack of all trades: thymosin α1 and its pleiotropy".” Ann N Y Acad Sci (2012). PMID: 23045964
- Chen JF, Chen SR, Lei ZY “"Safety and efficacy of Thymosin α1 in the treatment of hepatitis B...".” Front Immunol (2022). PMID: 35616850
- Ancell CD, Phipps J, Young L “"Thymosin alpha-1 (Review)".” Am J Health Syst Pharm (2001). PMID: 11381492
📚 Related Articles
Get Thymosin Alpha-1 from our recommended source — independently tested, COA-verified, USP <85> endotoxin compliant. Use code 4SS6SFTUGB at checkout.
Affiliate link · Full review